Definitive Contract HHSA290201100007C

This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Southern Research Institute, a nonprofit research organization. The contract is for the "Identification of Lead Compounds to Inhibit HIV-1 Regulatory Proteins" and has a ceiling value of $516,565. This is a cost-plus-fixed-fee delivery order contract, without a set-aside designation. Southern Research Institute holds...

This is a cost-plus-fixed-fee delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency of the U.S. Department of Health and Human Services (HHS), to Southern Research Institute, a non-profit organization based in Birmingham, Alabama. The $99,998.00 contract requires Southern Research to acquire and store chemical compound libraries, and conduct high-throughput screening to identify and characterize at least one agent that can block HIV...

This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services (HHS). The $496,282.56 cost-plus-fixed-fee contract was awarded to Southern Research Institute to identify anti-HIV therapeutics and topical microbicides through in vitro testing. The contract is part of NIAID's "In Vitro Testing Resource for HIV Therapeutics and Topical Microbicides" program and does not have a...

This is a cost-plus-fixed-fee contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Southern Research Institute to provide "OTHER FUNCTIONS" PRIMATE MODELS TO EVALUATE HIV PREVENTION THERAPEUTIC STRATEGIES. The $2,023,097.35 contract has a period of performance through December 31, 2008 and does not utilize a set-aside. Southern Research Institute, a non-profit organization, has a history of...

This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Southern Research Institute, a non-profit research organization. The $257,889.11 cost-plus-fixed-fee contract is for the identification of anti-HIV lead compounds, which is part of NIAID's "In Vitro Testing Resource for HIV Therapeutics and Topical Microbicides" program. The contract has no set-aside designation and is a...

The National Institute of Child Health and Human Development (NICHD) awarded a $7,569,946 cost-plus-fixed-fee delivery order to Westat, Inc., a prominent research and professional services firm, to provide support services for the prevention and treatment of HIV in HIV-affected adolescents in resource-constrained settings. This task order, designated as "TASK ORDER 4: SUPPORT SERVICES FOR THE PREVENTION AND TREATMENT THROUGH A COMPREHENSIVE CARE CONTINUUM FOR HIV-AFFECTED ADOLESCENTS IN...

This is a federal contract award to Southern Research Institute, a non-profit research organization in Birmingham, Alabama, by the National Institute of Allergy and Infectious Diseases (NIAID). The contract, valued at $214,117.04, is for the development and validation of assays to identify and evaluate the efficacy of anti-HIV therapeutics and topical microbicides. This work supports NIAID's in vitro testing resource for HIV therapeutics and topical microbicides program. The contract is a Cost...

This is a cost-plus-fixed-fee delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services (HHS), to Southern Research Institute, a non-profit organization. The $684,610.00 contract is for the identification of anti-HIV therapeutics and topical microbicides, which falls under NIAID's "In Vitro Testing Resource for HIV Therapeutics and Topical Microbicides" major program. The contract has a...

This federal contract was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Advanced Bioscience Laboratories, Inc. (ABL), a contract research and manufacturing organization specializing in gene therapies, vaccines, and immunotherapies. The $712,676.73 cost-plus-fixed-fee delivery order contract requires ABL to conduct a study to characterize the pharmacokinetic profile of a candidate...

The U.S. National Institute of Allergy and Infectious Diseases (NIAID) has awarded a Cost Plus Fixed Fee delivery order contract to Southern Research Institute, a non-profit research organization, to conduct confirmatory and specialized in vitro testing and screening of interventional agents for HIV therapeutics. The award, valued at $289,458.00, is a task order under NIAID's larger Preclinical Services for HIV Therapeutics Indefinite Delivery/Indefinite Quantity (ID/IQ) contract vehicle. This...